ShockWave Medical (SWAV) Stock Forecast, Price & News

ShockWave Medical (NASDAQ:SWAV) Frequently Asked Questions

Is ShockWave Medical a buy right now?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for ShockWave Medical in the last twelve months. There are currently 1 hold rating and 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ShockWave Medical stock.
View analyst ratings for ShockWave Medical or view top-rated stocks.

When is ShockWave Medical's next earnings date?

ShockWave Medical is scheduled to release its next quarterly earnings announcement on Monday, August 8th 2022.
View our earnings forecast for ShockWave Medical.

How were ShockWave Medical's earnings last quarter?

ShockWave Medical, Inc. (NASDAQ:SWAV) issued its quarterly earnings data on Monday, May, 9th. The company reported $0.39 EPS for the quarter, beating analysts' consensus estimates of $0.19 by $0.20. The firm had revenue of $93.70 million for the quarter, compared to analysts' expectations of $86.41 million. ShockWave Medical had a trailing twelve-month return on equity of 12.36% and a net margin of 9.70%. ShockWave Medical's quarterly revenue was up 193.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.68) earnings per share.
View ShockWave Medical's earnings history.

What guidance has ShockWave Medical issued on next quarter's earnings?

ShockWave Medical updated its FY 2022 earnings guidance on Monday, May, 23rd. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $435.00 million-$455.00 million, compared to the consensus revenue estimate of $417.90 million.

What price target have analysts set for SWAV?

6 Wall Street analysts have issued 12-month price targets for ShockWave Medical's shares. Their forecasts range from $176.00 to $255.00. On average, they expect ShockWave Medical's share price to reach $207.86 in the next twelve months. This suggests a possible upside of 31.3% from the stock's current price.
View analysts' price targets for ShockWave Medical or view top-rated stocks among Wall Street analysts.

Who are ShockWave Medical's key executives?

ShockWave Medical's management team includes the following people:

• Mr. Douglas E. Godshall M.B.A., Pres, CEO & Director (Age 57, Pay $972.39k)
• Mr. Daniel Puckett MBA, CFO, Principal Financial Officer & Sec. (Age 58, Pay $568.34k)
• Mr. Isaac Zacharias, Chief Commercial Officer (Age 47, Pay $571.37k) (LinkedIn Profile)
• Mr. Daniel Hawkins, Founder and Sr. Advisor (Age 55)
• Mr. John M. Adams, Co-Founder and Technical Advisor (Age 75)
• Mr. Mike Maszy, VP of Operations
• Ms. Trinh Phung, Chief Accounting Officer, Principal Accounting Officer & VP of Fin. (Age 44)
• Ms. Debbie Kaster, VP of Investor Relations
• Mr. Hajime Tada J.D., Gen. Counsel & Sec.
• Mr. Rob Williamson Jr., VP of Sales

What is Doug Godshall's approval rating as ShockWave Medical's CEO?

8 employees have rated ShockWave Medical CEO Doug Godshall on Glassdoor.com. Doug Godshall has an approval rating of 89% among ShockWave Medical's employees.

Who are some of ShockWave Medical's key competitors?

Some companies that are related to ShockWave Medical include Fresenius SE & Co. KGaA (FSNUY), Insulet (PODD), Teleflex (TFX), Abiomed (ABMD), NovoCure (NVCR), Globus Medical (GMED), Penumbra (PEN), Integra LifeSciences (IART), Inspire Medical Systems (INSP), Tandem Diabetes Care (TNDM), ICU Medical (ICUI), iRhythm Technologies (IRTC), Merit Medical Systems (MMSI), Inari Medical (NARI) and Haemonetics (HAE).
View all of SWAV's competitors.

What other stocks do shareholders of ShockWave Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other ShockWave Medical investors own include NVIDIA (NVDA), Walt Disney (DIS), Square (SQ), Trade Desk (TTD), Salesforce (CRM), Roku (ROKU), PayPal (PYPL), DexCom (DXCM), Alibaba Group (BABA) and Okta (OKTA).

When did ShockWave Medical IPO?

(SWAV) raised $75 million in an initial public offering (IPO) on Thursday, March 7th 2019. The company issued 5,000,000 shares at $14.00-$16.00 per share. Morgan Stanley and BofA Merrill Lynch served as the underwriters for the IPO and Wells Fargo Securities and Canaccord Genuity were co-managers.

What is ShockWave Medical's stock symbol?

ShockWave Medical trades on the NASDAQ under the ticker symbol "SWAV."

Who are ShockWave Medical's major shareholders?

ShockWave Medical's stock is owned by a number of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.25%), BlackRock Inc. (7.57%), Invesco Ltd. (3.91%), JPMorgan Chase & Co. (3.28%), Gilder Gagnon Howe & Co. LLC (3.24%) and State Street Corp (2.01%). Company insiders that own ShockWave Medical stock include Antoine Papiernik, Colin Cahill, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, Sofinnova Capital Vii Fcpr and Trinh Phung.
View institutional ownership trends for ShockWave Medical.

Which major investors are selling ShockWave Medical stock?

SWAV stock was sold by a variety of institutional investors in the last quarter, including Gilder Gagnon Howe & Co. LLC, Federated Hermes Inc., Nantahala Capital Management LLC, Renaissance Technologies LLC, JPMorgan Chase & Co., Bellevue Group AG, First Trust Advisors LP, and Ziegler Capital Management LLC. Company insiders that have sold ShockWave Medical company stock in the last year include Antoine Papiernik, Dan Puckett, Douglas Evan Godshall, Frank T Watkins, Isaac Zacharias, Kurt F Gallo, Laura Francis, and Trinh Phung.
View insider buying and selling activity for ShockWave Medical or view top insider-selling stocks.

Which major investors are buying ShockWave Medical stock?

SWAV stock was purchased by a variety of institutional investors in the last quarter, including Jennison Associates LLC, Invesco Ltd., Polar Asset Management Partners Inc., Eagle Asset Management Inc., Frontier Capital Management Co. LLC, Vanguard Group Inc., Lisanti Capital Growth LLC, and Jane Street Group LLC.
View insider buying and selling activity for ShockWave Medical or or view top insider-buying stocks.

How do I buy shares of ShockWave Medical?

Shares of SWAV can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ShockWave Medical's stock price today?

One share of SWAV stock can currently be purchased for approximately $158.27.

How much money does ShockWave Medical make?

ShockWave Medical has a market capitalization of $5.66 billion and generates $237.15 million in revenue each year. The company earns $-9.14 million in net income (profit) each year or $0.77 on an earnings per share basis.

How many employees does ShockWave Medical have?

ShockWave Medical employs 657 workers across the globe.

What is ShockWave Medical's official website?

The official website for ShockWave Medical is www.shockwavemedical.com.

How can I contact ShockWave Medical?

ShockWave Medical's mailing address is 5403 Betsy Ross Drive, Santa Clara CA, 95054. The company can be reached via phone at (510) 279-4262 or via email at [email protected].